Hello, this is GCCL.

GCCL will be participating in BIO KOREA 2026, which will be held at COEX, Seoul,

 from April 28 to 30, 2026, through business partnering meetings. 

Celebrating its 21st edition this year, BIO KOREA provides global collaboration opportunities 

through a wide range of programs. 

Among them, the Business Partnering program is designed to help participants identify 

the most suitable partners through an online scheduling system and maximize business outcomes.

At this year’s event, GCCL plans to focus on partnering meetings to engage in more in-depth discussions

with global pharmaceutical companies, biotech firms, CROs, and other industry stakeholders.

📢 GCCL Key Highlights

📅 Date
April 28 - 30, 2026

📍 Location
Coex, Seoul, Korea

As a leading Lab CRO supporting global clinical trials, GCCL provides integrated analytical solutions 

across the entire clinical trial lifecycle based on its Central Lab services and Bioanalytical Lab capabilities.

In particular, GCCL has supported domestic and international clients in clinical development 

through a broad range of analytical services, 

including biomarker analysis, immune monitoring, PK, ADA, and NAb analysis.

Through a flexible collaboration framework tailored to each project’s objectives and development stage, 

GCCL continues to expand its global partnerships.

At the upcoming BIO KOREA, we invite you to discover GCCL’s specialized analytical expertise 

and extensive global project experience, and to explore the best collaboration strategies for the success of your clinical trials.